title: Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation.
abstract: Paclitaxel (PTX), an antimicrotubular agent used in the treatment of ovarian and breast cancer, was encapsulated in nanoparticles (NPs) of poly(lactide-co-glycolide) (PLGA) and poly(ε-caprolactone) (PCL) polymers using the spray-drying technique. Morphology, size distribution, drug encapsulation efficiency, thermal degradation and drug release were characterized. MCF7 cells were employed to evaluate the efficacy of the systems on cell cycle and cytotoxicity. The particle size was in the range 0.8-1 µm. The incorporation efficiency of PTX was more than 80% in all NPs obtained. In vitro drug release took place during 35 days, and drug release rates were in the order PCL > PLGA 50:50 > PLGA 75:25. Unloaded NPs showed to be cytocompatible at MCF7 cells. PTX-loaded NPs demonstrated the release of the drug block cells in the G2/M phase. All PTX-loaded formulations showed their efficacy in killing MCF7 cells, mainly PTX-loaded PLGA 50:50 and PLGA 75:25 that cause a decrease in cell viability lower than 20%.
authors: Facultad de Farmacia, Departamento de Farmacología, Universidad Complutense de Madrid, Madrid, Spain.
authors: P
authors: P
authors: López-Gasco
authors: I
authors: I
authors: Iglesias
authors: J
authors: J
authors: Benedí
authors: R
authors: R
authors: Lozano
authors: J M
authors: JM
authors: Teijón
authors: M D
authors: MD
authors: Blanco
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D005260:Female; D016195:G2 Phase; D006801:Humans; D053758:Nanoparticles / Q000737:chemistry* / Q000627:therapeutic use; D017239:Paclitaxel / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011091:Polyesters
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D011091:Polyesters; D017239:Paclitaxel